Minerva Neurosciences
Utility Patents

Last updated:

List of all Minerva Neurosciences patents 2 in total

Status Patent
Grant
Utility: Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection External link
Filling date: 8 Sep 2025 Issue date: 10 Aug 2021
Grant
Utility: Compositions and methods for treating schizophrenia External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020

Showing 1 to 2 of 2 patents.